Mulay James

Mulay James is listed in filings as Director at CG Oncology, Inc. Common stock. This profile follows SEC Form 4 activity through Apr 20, 2026, including sale activity. Recent filings connect the profile to CG Oncology, Inc. Common stock (CGON). The current snapshot covers public activity from Jan 13, 2026 to Apr 20, 2026. Reported amounts are shown as $555.9K to $2.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.